Advertisement
New oncologic rehab program is tailored to managing the effects of cancer and its treatments
Oncology patients face an array of adverse effects from their cancer and its treatments, including pain, mobility issues and cognitive impairment. Eileen Slavin, DO, a physician in the Department of Physical Medicine and Rehabilitation within Cleveland Clinic’s Neurological Institute, recently launched an oncologic rehabilitation program to help patients maintain and regain function during their cancer treatment and recovery.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
“All of us have been affected by cancer in some way — through patients that we treat or family members,” Dr. Slavin says. “That’s why I’m excited about this work — it’s really important. I appreciate the collaboration of the diverse teams that are involved — all of our oncology teams, all our therapy teams, neurology, prosthetics and orthotics, nutrition and others.”
In a recent episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Slavin discusses the emerging field of cancer rehabilitation. The topics she covers include:
Click the podcast player above to listen to the 25-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.
This activity has been approved for AMA PRA Category 1 Credit™ and ANCC contact hours. After listening to the podcast, you can claim your credit here.
Podcast host Glen Stevens, DO, PhD: I suspect that one real growth area for you will be prehabilitation. Can you explain prehabilitation and what your role in it is?
Dr. Slavin: The concept of prehabilitation is for patients to prepare for something like a transplant or a big surgery, particularly when we know the outcomes could be potentially devastating — for instance, that they could end up with lymphedema, could have major mobility issues, could lose a lot of weight or might have a lower functional status. We try to identify patients who have about four to six weeks until their surgery or their transplant. That is better, of course, for solid tumor patients undergoing neoadjuvant chemotherapy because we can buy some time.
Advertisement
Prehabilitation essentially involves optimizing patients from three different perspectives — psychologically, physically and nutritionally. It includes looking at psychological health — referring patients to psychology, making sure they have good psychosocial support, such as ensuring that they have no transportation issues. It also includes helping with physical activity, or the physical function piece. That involves talking about exercise counseling, providing safety recommendations, giving them actual exercise prescriptions using the principle of FITT, or frequency, intensity, time and type. Then the final piece is nutrition, which involves collaborating with our dietician colleagues to prepare for the likelihood that the patient will lose weight and to make plans to help the patient maintain their caloric intake and consume enough protein to reduce loss of muscle mass and avoid sarcopenia.
All these aspects of the patient’s life will be affected. The idea of prehabilitation is to build the patient up before they get beaten up with all these therapies to treat their cancer, so that they have a stronger baseline to start from and will have a better and swifter recovery from treatment.
Advertisement
Advertisement
Polygenic risk score could help predict who will develop this aggressive breast cancer
Clinical trial to assess the value of nutritional, physical therapy and social supports prior to preoperative chemotherapy
Research to test clinical efficacy and cost-effectiveness versus standard-of-care rehab
Platinum-eligible phase 3 trial of enfortumab vedotin and pembrolizumab yields ‘unprecedented data’
Reassuring results, but patient education is still important
New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function
A new single-port system well-suited for oropharyngeal cancer treatment
Gene editing technology offers promise for treating multiple myeloma and other hematologic malignancies, as well as solid tumors